Search Tips
of 1 Next >
Results Found: 3
  • Bladder Cancer (MSKCC, Nat Genet 2016): Whole exome and targeted sequencing of 34 plasmacytoid-variant (signet ring cell) tumors of the bladder

    Authors
    Al-Ahmadie, Hikmat
    Iyer, Gopakumar Vasudeva
    Lee, Byron Hing Lung
    Scott, Sasinya Neka
    25 more author(s)...
    Description

    Whole-exome and targeted sequencing of plasmacytoid bladder cancer, an aggressive histologic variant with a high risk of disease-specific mortality. This dataset contains summary data visualizations and sequencing data of 34 plasmacytoid-variant (signet ring cell) tumors of the bladder from 31 patients. Clinical data includes detailed cancer type, mutation count, information about mutated genes, patient...

    Subject
    DNA Mutational Analysis
    Plasmacytoma/genetics
    Urinary Bladder Neoplasms
    Access Rights
    Free to All
  • Whole Exome Sequencing of Six Signet Ring/Plasmacytoid Variant Bladder Tumors

    Authors
    Solit, David
    Description

    In this study, six plasmacytoid bladder cancers were analyzed by whole exome sequencing. The results show loss of the CDH1 gene in every sample and correlate with E-cadherin loss of expression by immunohistochemistry. A separate validation cohort of plasmacytoid samples showed loss of E-cadherin expression by CDH1 mutation or promoter hypermethylation. The data includes information about the study,...

    Subject
    DNA Mutational Analysis
    Mutation
    Plasmacytoma/genetics
    Urinary Bladder Neoplasms
    Access Rights
    Application Required
  • TMB and Immunotherapy (MSKCC, Nat Genet 2019): Genomic and survival data from 1661 tumor-normal pairs from 1661 patients with various cancer types sequenced with the MSK-IMPACT assay.

    Description

    This dataset contains summary data visualizations and clinical data from a broad sampling of 1,661 samples of across multiple cancer types showing tumor mutational load and survival following immunotherapy from 1,661 patients. The data was gathered utilizing the MSK-IMPACT targeted sequencing test. The clinical data includes tumor type (based on the opensource OncoTree ontology developed at MSK),...

    Subject
    DNA Mutational Analysis
    Immunotherapy
    Mutation
    Tumor Burden
    Access Rights
    Free to All